Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPECTS: Alteplase in Posterior Circulation Stroke 4.5-24h
NCT05429476Phase 3Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2022
- Primary completion
- Aug 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in Posterior circulation ischemic stroke (PCIS), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Aug 2022; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
Posterior circulation ischemic stroke (PCIS)
Beyond the preview
Go deeper on NCT05429476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429476.